Patents by Inventor Cagri Besirli

Cagri Besirli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR ACTIVATING PYRUVATE KINASE
    Publication number: 20230374017
    Abstract: Provided herein are compositions and methods for activating pyruvate kinase (e.g., in a subject). In particular, provided herein are compositions and methods for treating a disease or condition (e.g., eye disease, blood disorders, or cancer) using pyruvate kinase activators.
    Type: Application
    Filed: July 21, 2021
    Publication date: November 23, 2023
    Inventors: CAGRI BESIRLI, JASON RECH, THOMAS WUBBEN, BRENNAN WATCH
  • Methods of inhibiting photoreceptor apoptosis by eliciting the Faim2 antiapoptotic pathway
    Patent number: 9192650
    Abstract: The present invention provides compositions and methods to prevent apoptosis. In particular, provided herein are compositions and methods which prevent FAS-mediated photoreceptor apoptosis.
    Type: Grant
    Filed: August 30, 2012
    Date of Patent: November 24, 2015
    Assignee: The Regents of the University of Michigan
    Inventors: David N. Zacks, Cagri Besirli
  • COMPOSITIONS AND METHODS OF INHIBITING PHOTORECEPTOR APOPTOSIS
    Publication number: 20130053328
    Abstract: The present invention provides compositions and methods to prevent apoptosis. In particular, provided herein are compositions and methods which prevent FAS-mediated photoreceptor apoptosis.
    Type: Application
    Filed: August 30, 2012
    Publication date: February 28, 2013
    Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: David N. Zacks, Cagri Besirli